Skip to main content
Publish date:

Dura Meets Earnings Estimates

Third-quarter profits fall short of year-ago levels.

Dura Pharmaceuticals (DURA) - Get VanEck Vectors Morningstar Durable Dividend ETF Report posted third-quarter results that fell short of last year's earnings but met analysts' expectations.

The San Diego based-company earned 9 cents a share, excluding charges, compared to 13 cents a share in the year-ago period, meeting the

First Call/Thomson Financial

consensus estimate of 10 analysts.

TheStreet Recommends

Dura also reported net losses, including nonrecurring charges, of $98.7 million, or $2.20 a share, for the third quarter. Pharmaceutical sales in the third quarter rose 7% to $58 million from $54.2 million, while total revenue fell to $70.1 million, from $71.6 million a year earlier.